Physician profile
Eric J Mayuga
NPI 1407047152
$1,437.25
in general payments reported to CMS, 2019-2025
10 companies · $71.61 in 2025
The $71.61 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $50.00 · 2021: $12.49 · 2022: $186 · 2023: $169 · 2024: $713 · 2025: $71.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $596 · Food and Beverage: $324 · Honoraria: $33.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $595.62 |
| Food and Beverage | $324.49 |
| Honoraria | $33.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hu-Friedy Mfg. Co., LLC | $501.68 | 2024 | |
| Kulzer, LLC | $196.08 | 2024 | |
| Ultradent Products INC | $168.53 | 2022 | |
| Benco Dental Supply Co. | $137.24 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $131.90 | 2019 | |
| Zimvie INC. | $113.66 | 2023-2025 | |
| Straumann USA LLC | $91.98 | 2022-2023 | |
| Coltene Whaledent INC. | $62.49 | 2020-2021 | |
| Septodont INC. | $18.94 | 2025 | Biodentine |
| Philips North America LLC | $14.75 | 2024 | (E55) Oral Health Care Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mayuga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.